ResultsIQ › Latest results › Godrej Agrovet Limited
Godrej Agrovet Limited Q2 FY27 earnings call summary
NSE: GODREJAGRO · BSE: 540743
Earnings call of 6 Nov 2026, summarised by AI from the filing.
Godrej Agrovet's Q2 FY27 revenue rose 17% to ₹2,995 cr with PAT up 22%, but a tough Rabi season and El Niño hit agchem.
Key takeaways
- FY27 PBT Double-digit PBT growth intent retained for FY27, though management says it has become tougher.
- Oil palm OER Q2 OER fell to 18.9% from heat stress, with September back to last year and October marginally ahead.
- Foods B2C B2C grew 50% and salience rose to 38%, helped by quick-commerce and new products.
- Agchem risk A tough Rabi season is expected as reservoir levels have crashed, hitting crop care and Astec.
Godrej Agrovet Limited Q2 FY27 results
As filed: Revenue ₹2,995 cr (+17% year on year), EBITDA ₹200 cr (−7% year on year), PAT ₹103 cr (+22% year on year), EBITDA margin 6.7% (−167 bps).
The Q2 FY27 score, against the company's own trend, is for premium members.
Earlier results and the share price after them
- Q1 FY27: Revenue ₹2,855 cr (+9% year on year), EBITDA ₹240 cr (−11% year on year), PAT ₹128 cr (−14% year on year), EBITDA margin 8.4% (−188 bps). Score 37 of 100, Below trend. Revenue growth was above the company's own trend; EBITDA and profit growth were well below it. EBITDA margin fell 188 bps year on year. Share price after the results: +13.8% in 30 days (Nifty 500: −2.0%).
- Q4 FY26: Revenue ₹2,333 cr (+9% year on year), EBITDA ₹139 cr (−5% year on year), PAT ₹102 cr (+55% year on year), EBITDA margin 6.0% (−89 bps). Score 38 of 100, Below trend. Revenue growth was well above the company's own trend; EBITDA growth was below it; profit growth was above it. EBITDA margin fell 89 bps year on year. Other income 56% of PBT. Consolidated profit +55% but standalone -5%. Revenue fell 14% from last quarter. Share price after the results: −3.4% in 29 days (Nifty 500: −0.1%).
- Q3 FY26: Revenue ₹2,718 cr (+11% year on year), EBITDA ₹242 cr (+10% year on year), PAT ₹110 cr (+23% year on year), EBITDA margin 8.9% (−9 bps). Score 60 of 100, In line with trend. Revenue growth was well above the company's own trend; EBITDA growth was below it; profit before exceptional items growth was in line with it. EBITDA margin was flat year on year. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: +11.2% in 30 days (Nifty 500: −3.2%).
- Q2 FY26: Revenue ₹2,567 cr (+5% year on year), EBITDA ₹214 cr (−4% year on year), PAT ₹84.0 cr (−13% year on year), EBITDA margin 8.3% (−77 bps). Score 31 of 100, Below trend. Revenue growth was above the company's own trend; EBITDA and profit growth were below it. EBITDA margin fell 77 bps year on year. Tax rate 41%. Consolidated profit -12% but standalone +34%. Profit fell 44% from last quarter. Share price after the results: −10.2% in 30 days (Nifty 500: +0.7%).
- Q1 FY26: Revenue ₹2,614 cr (+11% year on year), EBITDA ₹269 cr (+19% year on year), PAT ₹149 cr (+13% year on year), EBITDA margin 10.3% (+64 bps). Score 62 of 100, In line with trend. Revenue growth was well above the company's own trend; EBITDA growth was below it; profit growth was in line with it. EBITDA margin rose 64 bps year on year. Share price after the results: −7.6% in 30 days (Nifty 500: +0.1%).
- Q4 FY25: Revenue ₹2,134 cr (0% year on year), EBITDA ₹146 cr (−1% year on year), PAT ₹66.0 cr (+2% year on year), EBITDA margin 6.8% (−9 bps). Score 35 of 100, Below trend. Revenue growth was in line with the company's own trend; EBITDA growth was well below it; profit growth was below it. EBITDA margin was flat year on year. Revenue fell 13% from last quarter. Share price after the results: −1.0% in 30 days (Nifty 500: +3.5%).
- Q3 FY25: Revenue ₹2,450 cr (+4% year on year), EBITDA ₹220 cr (+38% year on year), PAT ₹110 cr (+33% year on year), EBITDA margin 9.0% (+220 bps). Score 67 of 100, Above trend. Revenue growth was above the company's own trend; EBITDA and profit growth were in line with it. EBITDA margin rose 220 bps year on year.
Past price moves after results do not indicate future moves. Not a recommendation.
Godrej Agrovet Limited earnings call, investor presentation and press release summaries
- Q2 FY27: Earnings call (6 Nov 2026), Results deck (6 Nov 2026)
- Q1 FY27: Earnings call (6 Aug 2026), Results deck (5 Aug 2026)
- Q4 FY26: Earnings call (4 May 2026), Results deck (30 Apr 2026), Results deck (2 May 2026)
- Q3 FY26: Earnings call (4 Feb 2026), Results deck (3 Feb 2026), Results press release (3 Feb 2026)
- Q2 FY26: Earnings call (6 Nov 2025), Results deck (5 Nov 2025)
- Q1 FY26: Earnings call (7 Aug 2025), Results deck (6 Aug 2025), Results press release (6 Aug 2025)
- Q4 FY25: Earnings call (5 May 2025), Results deck (30 Apr 2025)
Figures from the company's filings with NSE and BSE. Not investment advice.